Letter by Rodriguez et al Regarding Article, “Fractional Flow Reserve–Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial”
Circulation · 2024
DOI: 10.1161/circulationaha.123.067446 ↗Kurz gefasst
Leserbrief in der Zeitschrift Circulation, 2024. Verfasst von Alfredo E Rodriguez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Cardiology, Otamendi Hospital, Buenos Aires, Argentina (A.E.R.). Hauptthemen laut MEDLINE: Coronary Artery Disease, Fractional Flow Reserve, Myocardial, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Interventional Cardiology, Otamendi Hospital, Buenos Aires, Argentina (A.E.R.).
- Cardiovascular Research Center, Buenos Aires, Argentina (A.E.R., C.F.-P., J.M.).
ORCID-Profile: Alfredo E Rodriguez, Carlos Fernandez-Pereira, Juan Mieres
Zitieren
APA
Rodriguez, A. E., Fernandez-Pereira, C., & Mieres, J. (2024). Letter by Rodriguez et al Regarding Article, “Fractional Flow Reserve–Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial”. Circulation. https://doi.org/10.1161/circulationaha.123.067446
Vancouver
Rodriguez AE, Fernandez-Pereira C, Mieres J. Letter by Rodriguez et al Regarding Article, “Fractional Flow Reserve–Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial”. Circulation. 2024. doi:10.1161/circulationaha.123.067446
BibTeX
@article{Rodriguez2024,
author = {Rodriguez, Alfredo E and Fernandez-Pereira, Carlos and Mieres, Juan},
title = {Letter by Rodriguez et al Regarding Article, “Fractional Flow Reserve–Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial”},
journal = {Circulation},
year = {2024},
doi = {10.1161/circulationaha.123.067446}
}
EUVIMED